Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
Looking Back at the First Trump Administration's Tech Priorities
In his first term, Donald Trump supported cybersecurity, space policy and artificial intelligence development.
4m read -
Labor CAIO Outlines Responsible and Ethical AI Priorities, Use Cases
Department of Labor Chief AI Officer Mangala Kuppa outlined how her role is shaping the agency’s artificial intelligence strategy.
20m watch -
Elevating Cybersecurity in the Intelligence Community
The Intelligence Community is developing strategies to protect data and strengthen resiliency against emerging cyber threats.
30m watch -
Storytelling Miniseries: Mastering Mindful Communication with Elizabeth Barry
Join us as Elizabeth shares her unique approach to communication, offering tips and strategies for personal growth and leadership through storytelling.
17m listen
